«

»

Effect of Aspirin on All-Cause Mortality in the Healthy Elderly

The Aspirin in Reducing Events in the Elderly (ASPREE) trial was a primary prevention trial that was established to investigate whether the daily use of 100 mg of enteric-coated aspirin would prolong the healthy life span of older adults. The trial, which was conducted in Australia and the United…

Read the full post at The New England Journal of Medicine: Search Results in Health Policy and Reform
Vote This Post DownVote This Post Up (No Ratings Yet)
Explore the Archive